Compare ACOG & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | AMWL |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 111.4M |
| IPO Year | N/A | 2020 |
| Metric | ACOG | AMWL |
|---|---|---|
| Price | $5.08 | $4.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 7 |
| Target Price | ★ $18.00 | $8.33 |
| AVG Volume (30 Days) | 84.0K | ★ 130.8K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,427,199.00 | ★ $265,023,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $143.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.33 |
| 52 Week Low | $3.75 | $3.71 |
| 52 Week High | $11.54 | $12.95 |
| Indicator | ACOG | AMWL |
|---|---|---|
| Relative Strength Index (RSI) | 32.34 | 61.30 |
| Support Level | $5.66 | $3.92 |
| Resistance Level | $6.74 | $4.14 |
| Average True Range (ATR) | 0.41 | 0.22 |
| MACD | -0.06 | 0.13 |
| Stochastic Oscillator | 0.00 | 91.48 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.